Floatz logo

Decitabine

Conditioning

Nanfang Hospital, Southern Medical UniversitySmall moleculePhase 2/3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Conditioning cohort.

Asset / SponsorPhaseRating
Evomela
First Affiliated Hospital of Zhejiang University
Phase 3BB
Fludarabine
First Affiliated Hospital of Zhejiang University
Phase 3BB
Cyclophosphamide
First Affiliated Hospital Xi'an Jiaotong University
Phase 2/3B
Busulphan
First Affiliated Hospital Xi'an Jiaotong University
Phase 2/3B
Venetoclax
First Affiliated Hospital of Zhejiang University
Phase 3B

View all 15 →

Same molecule, other indications

Decitabine is also rated in:

disease related to hematopoietic stem cell transplantDormant
BBB
Indicative ·
72 / 100
View asset →
acute myeloid leukemia with t(8;21)(q22;q22) translocationDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemiaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →